Place of Origin: | China |
Brand Name: | Evergreen |
Certification: | ISO,Kosher, B.V. |
Model Number: | 98% citicoline sodium |
Minimum Order Quantity: | 1kg |
---|---|
Price: | $3/kg |
Packaging Details: | 25kg/drum or 1kg aluminum bag |
Delivery Time: | ship immediately |
Payment Terms: | t/t |
Supply Ability: | 3000kg/month |
CAS No.: | 33818-15-4 | Application: | Pharmaceutical |
---|---|---|---|
State: | Powder |
sara@extractspowder.com
Citicoline Sodium CAS No.: 33818-15-4
1) Product name: Citicoline Sodium
2) CAS No.: 33818-15-4
3) Molecular Weight: 510.31
4) Appearance: White crystalline powder
5) Specification : 98% min
6) Molecular Formula : C14H25N4NaO11P2
Citicoline Sodium, also known as cytidine diphosphate-choline (CDP-Choline) & cytidine 5'-diphosphocholine is a psychostimulant/nootropic. It is an intermediate in the generation of phosphatidylcholine from choline. Studies suggest that CDP-choline supplements increase dopamine receptor densities, and suggest that CDP choline supplementation helps prevent memory impairment resulting from poor environmental conditions.Preliminary research has found that citicoline supplements help improve focus and mental energy and may possibly be useful in the treatment of attention deficit disorder.
Application:
1.Citicoline Sodium is a brain chemical that occurs naturally in the body.
2.As a medicine, Citicoline Sodium is taken by mouth as a supplement or given by IV or as a shot.
3.Citicoline Sodium is used for Alzheimer's disease and other types of dementia, head trauma, cerebrovascular disease such as stroke, age-related memory loss, Parkinson's disease, and glaucoma.
4.The main indications of Citicoline Sodium are acute traumatic brain injury and brain consciousness after the operation. Moreover, Citicoline Sodium can treat central nervous system dysfunction and unconsciousness caused by acute injury, paralysis agitans, tinnitus and nerve deafness, and poisoning caused by sleeping pills. In recent years, Citicoline Sodium is widely used in clinical for treatment of ischemic stroke, cerebral arteriosclerosis, multi-infarct dementia, Alzheimer's disease, and children